Nkx2-2 Antikörper (AA 1-119)
Kurzübersicht für Nkx2-2 Antikörper (AA 1-119) (ABIN5707913)
Target
Alle Nkx2-2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-119
-
Aufreinigung
- Purified
-
Reinheit
- Protein A affinity chromatography
-
Immunogen
- A human partial recombinant protein (within amino acids 1-119) was used as the immunogen for this recombinant NKX2.2 antibody.
-
Isotyp
- IgG kappa
-
-
-
-
Applikationshinweise
-
Titering of the recombinant NKX2.2 antibody may be required for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the recombinant NKX2.2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Nkx2-2 (NK2 Homeobox 2 (Nkx2-2))
-
Andere Bezeichnung
- NKX2.2
-
Hintergrund
- Expression of NKX2.2 has been found in neuroendocrine tumors of the gut, making it a potential marker for the study of gastrointestinal neuroendocrine tumors. More recently, NKX2.2 protein was identified as a target of EWS-FLI-1, the fusion protein specific to Ewing sarcoma, and was shown to be differentially upregulated in Ewing sarcoma on the basis of array-based gene expression analysis. Antibody to NKX2.2 detects a valuable marker for Ewing sarcoma, with a sensitivity of 93 % and a specificity of 89 %, and aids in the differential diagnosis of small round cell tumors.
-
Gen-ID
- 4821
-
Pathways
- Dopaminergic Neurogenesis
Target
-